Nakata R - Search Results

1

Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNA.

Shiratori Y, Yokosuka O, Nakata R, Ihori M, Hirota K, Katamoto T, Unuma T, Okano K, Ikeda Y, Hirano M, Kawase T, Takano S, Matsumoto K, Ohashi Y, Omata M. Shiratori Y, et al. Among authors: nakata r. Hepatology. 1999 May;29(5):1573-80. doi: 10.1002/hep.510290529. Hepatology. 1999. PMID: 10216145 Clinical Trial.

2

Real-time monitoring of HCV-RNA by single tube assay kit and potential importance for predicting virological sustained response in patients with chronic hepatitis C.

Shiratori Y, Kato N, Tamatsukuri S, Yoshida H, Kawabe T, Nakata R, Okano K, Omata M. Shiratori Y, et al. Among authors: nakata r. J Gastroenterol Hepatol. 1996 Aug;11(8):705-11. doi: 10.1111/j.1440-1746.1996.tb00318.x. J Gastroenterol Hepatol. 1996. PMID: 8872765

3

Sustained viral response is rarely achieved in patients with high viral load of HCV RNA by excessive interferon therapy.

Shiratori Y, Kato N, Yoshida H, Nakata R, Ihori M, Imazeki F, Yokosuka O, Kawase T, Katamoto T, Unuma T, Nakamura A, Ikegami F, Hirota K, Omata M. Shiratori Y, et al. Among authors: nakata r. Dig Dis Sci. 2000 Mar;45(3):565-74. doi: 10.1023/a:1005457510354. Dig Dis Sci. 2000. PMID: 10749334

4

Different turnover rate of hepatitis C virus clearance by different treatment regimen using interferon-beta.

Shiratori Y, Perelson AS, Weinberger L, Imazeki F, Yokosuka O, Nakata R, Ihori M, Hirota K, Ono N, Kuroda H, Motojima T, Nishigaki M, Omata M. Shiratori Y, et al. Among authors: nakata r. J Hepatol. 2000 Aug;33(2):313-22. doi: 10.1016/s0168-8278(00)80373-6. J Hepatol. 2000. PMID: 10952250 Clinical Trial.

5

Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival.

Shiratori Y, Ito Y, Yokosuka O, Imazeki F, Nakata R, Tanaka N, Arakawa Y, Hashimoto E, Hirota K, Yoshida H, Ohashi Y, Omata M; Tokyo-Chiba Hepatitis Research Group. Shiratori Y, et al. Among authors: nakata r. Ann Intern Med. 2005 Jan 18;142(2):105-14. doi: 10.7326/0003-4819-142-2-200501180-00009. Ann Intern Med. 2005. PMID: 15657158 Clinical Trial.

6

Inhibition of hepatic metastasis of colon carcinoma by asialo GM1--positive cells in the liver.

Shiratori Y, Nakata R, Okano K, Komatsu Y, Shiina S, Kawase T, Sugimoto T, Omata M, Tanaka M. Shiratori Y, et al. Among authors: nakata r. Hepatology. 1992 Aug;16(2):469-78. doi: 10.1002/hep.1840160228. Hepatology. 1992. PMID: 1639356

7

Production of chemotactic factor, interleukin-8, from hepatocytes exposed to ethanol.

Shiratori Y, Takada H, Hikiba Y, Nakata R, Okano K, Komatsu Y, Niwa Y, Matsumura M, Shiina S, Omata M, et al. Shiratori Y, et al. Among authors: nakata r. Hepatology. 1993 Dec;18(6):1477-82. Hepatology. 1993. PMID: 8244273

8

High viral eradication with a daily 12-week natural interferon-beta treatment regimen in chronic hepatitis C patients with low viral load. IFN-beta Research Group.

Shiratori Y, Nakata R, Shimizu N, Katada H, Hisamitsu S, Yasuda E, Matsumura M, Narita T, Kawada K, Omata M; IFN-beta Research Group. Shiratori Y, et al. Among authors: nakata r. Dig Dis Sci. 2000 Dec;45(12):2414-21. doi: 10.1023/a:1005655428563. Dig Dis Sci. 2000. PMID: 11258568 Clinical Trial.

9

Delayed development of hepatocellular carcinoma during long-term follow-up after eradication of hepatitis C virus by interferon therapy.

Ito Y, Yamamoto N, Nakata R, Kato Y, Iori M, Sakai K, Takemura T, Tateishi R, Yoshida H, Kawabe T, Omata M. Ito Y, et al. Among authors: nakata r. World J Gastroenterol. 2005 Dec 7;11(45):7218-21. doi: 10.3748/wjg.v11.i45.7218. World J Gastroenterol. 2005. PMID: 16437676 Free PMC article.

10

Involvement of the biliary system in autoimmune pancreatitis: a follow-up study.

Hirano K, Shiratori Y, Komatsu Y, Yamamoto N, Sasahira N, Toda N, Isayama H, Tada M, Tsujino T, Nakata R, Kawase T, Katamoto T, Kawabe T, Omata M. Hirano K, et al. Among authors: nakata r. Clin Gastroenterol Hepatol. 2003 Nov;1(6):453-64. doi: 10.1016/s1542-3565(03)00221-0. Clin Gastroenterol Hepatol. 2003. PMID: 15017645

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191 results

Search Page